Cargando…

Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma

Most malignant mesotheliomas (MPMs) frequently show activated forms of Yes-associated protein 1 (YAP1) and transcriptional co-activator with PDZ-binding motif (TAZ), which transcriptionally regulates the receptor for hyaluronic acid-mediated motility (RHAMM). As RHAMM is involved in cell migration a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shigeeda, Wataru, Shibazaki, Masahiko, Yasuhira, Shinji, Masuda, Tomoyuki, Tanita, Tatsuo, Kaneko, Yuka, Sato, Tatsuhiro, Sekido, Yoshitaka, Maesawa, Chihaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706831/ https://www.ncbi.nlm.nih.gov/pubmed/29212185 http://dx.doi.org/10.18632/oncotarget.20750

Ejemplares similares

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
por: Sato, Tatsuhiro, et al.
Publicado: (2023)

NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
por: Kasai, Shuya, et al.
Publicado: (2016)

Involvement of C-terminal truncation mutation of kinesin-5 in resistance to kinesin-5 inhibitor
por: Saeki, Eri, et al.
Publicado: (2018)

Correction: Involvement of C-terminal truncation mutation of kinesin-5 in resistance to kinesin-5 inhibitor
por: Saeki, Eri, et al.
Publicado: (2019)

NF2 alteration in mesothelioma
por: Sekido, Yoshitaka, et al.
Publicado: (2023)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification
por: Tatemichi, Yoshinori, et al.
Publicado: (2015)

NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
por: Sato, Tatsuhiro, et al.
Publicado: (2018)

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019)

Hyaluronic acid in viscous malignant mesothelioma pleural effusion
por: Cheah, Hui Min, et al.
Publicado: (2020)

Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
por: Takehara, Yusuke, et al.
Publicado: (2018)

Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
por: Takehara, Yusuke, et al.
Publicado: (2018)

YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations
por: Cunningham, Richard, et al.
Publicado: (2023)

DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

YAP and TAZ regulate cell volume
por: Perez-Gonzalez, Nicolas A., et al.
Publicado: (2019)

Mechanisms of YAP/TAZ transcriptional control
por: Battilana, Giusy, et al.
Publicado: (2021)

YAP/TAZ in Bone and Cartilage Biology
por: Zarka, Mylène, et al.
Publicado: (2022)

YAP/TAZ dull the STING of aging
por: Francisco, Jamie, et al.
Publicado: (2022)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

Characterization of PAX9 variant P20L identified in a Japanese family with tooth agenesis
por: Murakami, Akiko, et al.
Publicado: (2017)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)

TAZ and YAP are frequently activated oncoproteins in sarcomas
por: Fullenkamp, Colleen A., et al.
Publicado: (2016)

Multifaceted regulation and functions of YAP/TAZ in tumors
por: Liu, Huirong, et al.
Publicado: (2018)

YAP and TAZ are dispensable for physiological and malignant haematopoiesis
por: Donato, Elisa, et al.
Publicado: (2018)

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
por: Azad, Taha, et al.
Publicado: (2019)

YAP and TAZ in Lung Development: The Timing Is Important
por: Warburton, David
Publicado: (2020)

Emerging Principles in the Transcriptional Control by YAP and TAZ
por: Lopez-Hernandez, Alejandro, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

YAP/TAZ: Molecular pathway and disease therapy
por: Wei, Yuzi, et al.
Publicado: (2023)

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients
por: Enemark, Marie Beck, et al.
Publicado: (2022)

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
por: Dubois, Fatéméh, et al.
Publicado: (2022)

Yap/Taz transcriptional activity is essential for vascular regression via Ctgf expression and actin polymerization
por: Nagasawa-Masuda, Ayumi, et al.
Publicado: (2017)

Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma
por: Hagiyama, Man, et al.
Publicado: (2022)

Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018)

Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer
por: Naor, David
Publicado: (2016)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

YAP/TAZ initiate and maintain Schwann cell myelination
por: Grove, Matthew, et al.
Publicado: (2017)

The role of YAP/TAZ activity in cancer metabolic reprogramming
por: Zhang, Xiaodong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fj47nbus91r81h255igc7l0kv1